피플바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 휴먼데이타, was filed 20 Mar 2026.
피플바이오: what insiders have been doing
This page follows insider dealings at 피플바이오 as filed with DART (FSS), a company from the Health Care sector. In the past year (2 November 2025 to 2 November 2026), 10 filings came from 2 insiders.
Only purchases show up on the open market, 2 purchases in all, filed by 1 insider. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The most recent open-market purchase was published on 20 March 2026, 235 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. That lag is the time during which only the insider knows about the trade.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 10 filings, this issuer sits above that mark. Since 2021, the database holds 18 purchases and 4 sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -25.3%Entry ₩751 · Close 30 Oct 2026 ₩561
- -33.9%Entry ₩3,685 · Close at T+365 ₩2,435
- -44.0%Entry ₩6,791 · Close at T+365 ₩3,800
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20260424000365
- 2,246,326 sharesKRXDART:20260320000794Canonical exit: 11 Jun 2026 (T+90)
- ●Executives0DART
- 0KRXDART:20260304000590
- 28,825,910 sharesKRXDART:20260108000061Canonical exit: 31 Mar 2026 (T+90)
- 1,019,633 sharesKRXDART:20241112000432
- 2,613,578 sharesKRXDART:20240719000149Canonical exit: 10 Oct 2024 (T+90)
- ●Executives0DART
- 2,613,578 sharesKRXDART:20231113000771Canonical exit: 8 Feb 2024 (T+90)
- 169,105 sharesShareKRXDART:20231027000096
- 296,193 sharesShareKRXDART:20231026000237
- 109,759 sharesShareKRXDART:20231026000218
- 2,613,578 sharesKRXDART:20231026000244Canonical exit: 18 Jan 2024 (T+90)
- 393,319 shares@ ₩509.43266.3% of flowShareKRXDART:20230927000386
- 2,613,578 sharesKRXDART:20230927000394Canonical exit: 17 Dec 2023 (T+90)
- 145,109 shares@ ₩386.87796.0% of flowShareKRXDART:20230926000069
- 241,990 shares@ ₩448.12984.5% of flowShareKRXDART:20230926000669
- 182,141 sharesShareKRXDART:20230922000030Canonical exit: 11 Dec 2023 (T+90)
25 of 46 declarations
About 피플바이오
PeopleBio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
